Avita Medical (AVH) Short Interest
Avita Medical (ASX:AVH) had 0.15% of shares reported as short positions as of 24 Aug 2026, representing 122,156 shares. Avita Medical operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Avita Medical
Avita Medical Inc. is a regenerative medicine company specializing in therapeutic skin restoration. Their flagship product, the RECELL System, is FDA-approved for treating thermal burn wounds and full-thickness skin defects. The company leverages patient-derived skin cells to enhance healing and accelerate recovery, positioning itself as a leader in acute wound care solutions.
Short position
Avita Medical (ASX:AVH) has 0.15% of its shares on issue reported as short positions as of 24 Aug 2026, or about 122,156 shares. Over the past 30 days that figure has fallen 0.12 percentage points, and over 90 days it has fallen 0.28 percentage points. Its highest recorded short interest was 8.80% in December 2020. AVH is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 35, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4AVH intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Avita Medical Inc.
Latest AVH news
All news- AVITA Medical (ASX:AVH) Shares Rise 4.06% as Commercial Momentum Builds - Kalkine
googlenews
- AVITA Medical (ASX:AVH) Jumps 23.18% as Shares Extend a 67% One-Year Recovery - Kalkine
googlenews
- AVITA Investor Webinar Slides on PermeaDerm
asx
- AVITA announces positive PermeaDerm study results
asx
- AVITA Medical Inc (ASX:AVH) Shares Reach 52-Week High at AUD 2.30 - Kalkine
googlenews
About
website
address
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss AVH
Start a research thread or post the first pulse update